Qol Holdings Co (TSE:3034) Total Liabilities : 円64,248 Mil (As of Dec. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Qol Holdings Co Total Liabilities?

Qol Holdings Co's Total Liabilities for the quarter that ended in Dec. 2023 was 円64,248 Mil.

Qol Holdings Co's quarterly Total Liabilities increased from Jun. 2023 (円54,737.00 Mil) to Sep. 2023 (円57,106.00 Mil) and increased from Sep. 2023 (円57,106.00 Mil) to Dec. 2023 (円64,248.00 Mil).

Qol Holdings Co's annual Total Liabilities declined from Mar. 2021 (円58,737.00 Mil) to Mar. 2022 (円52,105.00 Mil) but then increased from Mar. 2022 (円52,105.00 Mil) to Mar. 2023 (円53,051.00 Mil).

Qol Holdings Co Total Liabilities Historical Data

The historical data trend for Qol Holdings Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qol Holdings Co Total Liabilities Chart

Qol Holdings Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Total Liabilities

Get a 7-Day Free Trial

55,221.00

61,870.00

58,737.00

52,105.00

53,051.00

Qol Holdings Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Liabilities	Get a 7-Day Free Trial															58,254.00	53,051.00	54,737.00	57,106.00	64,248.00

Qol Holdings Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Qol Holdings Co's Total Liabilities for the fiscal year that ended in Mar. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	36330	+	(14038	+	1820
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	863)
	=	53,051

Total Liabilities	=	Total Assets (A: Mar. 2023 )	-	Total Equity (A: Mar. 2023 )
	=	101905	-	48854
	=	53,051

Qol Holdings Co's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	46767	+	(14827	+	1779
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	875)
	=	64,248

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	115922	-	51674
	=	64,248

Qol Holdings Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Qol Holdings Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Qol Holdings Co (TSE:3034) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Qol Holdings Co Ltd (TSE:3034) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

4-3-1, Toranomon, 37th Floor, Shiroyama Trust Tower, Minato-ku, Tokyo, JPN, 105-8452

Website

https://www.qolhd.co.jp

Qol Holdings Co Ltd provides pharmacy services under health insurance and sells pharmaceutical products. Its mission is to create healthy and comfortable living environments for everybody in those communities. The company operates through: Pharmacy and BPO segments. Under the Pharmacy segment the company puts customers first in-store development strategy, which is based on building one-on-one relationships with drug-prescribing clinics and hospitals in order to get the pharmacy services that include medical information. The BPO contracting segment includes clinical trials and projects and develops pamphlets and websites for medical institutions to promote sales of pharmaceutical products and provide advice on proper pharmaceutical product.

Qol Holdings Co (TSE:3034) Headlines

No Headlines